A startup hoping to redefine “all-in-one glucose meter” is
looking for a $3 million boost for its one-click diabetes testing device that
combines a lancing device with nanotechnology sensors that measure blood
glucose.
Pepex Biomedical Inc.’s
blood glucose meter, the Trio, combines all of
the diabetes testing materials in one device and replaces test strips with
disposable, miniaturized enzymatic-based biosensors. The advantage, according
to the company, is that it requires no handling of sharps and reduces
environmental and user-induced error by eliminating test strips. The device
doesn’t actually draw blood, according to CFO Joseph Driver. Rather, it tests
the blood at the tissue source.